1350P Survival benefits of local treatment (LT) for brain metastases (BMs) in patients (pts) with EGFR-mutant non-small cell lung cancer (EGFR-mt NSCLC) treated with osimertinib
| Autor: | Tozuka, T., Noro, R., Mizutani, H., Kurimoto, F., Hakozaki, T., Hisakane, K., Naito, T., Takahashi, S., Taniuchi, N., Yajima, C., Hosomi, Y., Hirose, T., Minegishi, Y., Okano, T., Kamio, K., Yamaguchi, T., Seike, M. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S777-S777 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|